Trupanion reported third-quarter 2026 results for the period ended September 30, 2026. Total revenue rose 11% to $405.6 million, net income was $9.3 million, or $0.21 per diluted share, compared with $5.9 million, or $0.13 per diluted share, a year earlier. The company also repurchased about $25.0 million of its stock in the quarter, leaving about $75.0 million available under its $100.0 million buyback program.
Total revenue was $405.6 million, up 11% from $366.9 million in Q3 2025.
Net income was $9.3 million, or $0.21 per diluted share, versus $5.9 million, or $0.13 per diluted share, in Q3 2025.
Adjusted EBITDA was $20.8 million, compared with $19.6 million in Q3 2025.
Operating cash flow was $30.7 million and free cash flow was $28.5 million in Q3 2026; about $25.0 million of stock was repurchased in the quarter.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Trupanion's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.44B
+11.9%
$0.45
—
1.4%
FY2024
$1.29B
+16.0%
$-0.23
—
-0.7%
FY2023
$1.11B
+22.5%
$-1.08
—
-4.0%
FY2022
$905.18M
+29.5%
$-1.10
—
-4.9%
FY2021
$698.99M
+39.2%
$-0.89
—
-5.1%
Frequently asked questions
When is Trupanion's next earnings date?
Trupanion has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Trupanion earn last quarter?
For the quarter ended Sep 2026, Trupanion reported diluted EPS of $0.21 (+61.5% year over year) on revenue of $405.59M (+10.5%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.